what tirzepatide is
Tirzepatide is the active molecule in Mounjaro® and Zepbound®. It works on two appetite-signaling pathways at once rather than one, which is what separates it from earlier weight-loss drugs. In trials comparing it directly to semaglutide, tirzepatide produced stronger average weight loss. Compounded tirzepatide is the same molecule, prescribed by a licensed physician, at a lower cost.
The two pathways are GLP-1 and GIP, both hormones your gut releases after eating. GLP-1 tells the brain you've had enough. GIP works through a different receptor and adds a second signal that reinforces satiety and supports blood-sugar management. When both are activated together, most people find that hunger settles more consistently and food simply becomes less compelling.
Semaglutide, the molecule in Ozempic® and Wegovy®, activates GLP-1 alone. Tirzepatide activates both, and that appears to be why the results tend to be stronger.
what the research actually shows
In the main Phase 3 trial for tirzepatide in obesity, people on the highest dose lost an average of 22.5% of body weight over 72 weeks.[1] For most people, that's not a rounding error. That's weight that wouldn't move through diet and exercise alone finally moving.
The comparison with semaglutide has since been run head to head. Over 72 weeks in adults with obesity and without diabetes, tirzepatide averaged a 20.2% reduction in body weight against 13.7% for semaglutide.[2] The dual mechanism is the most likely explanation, though individual response varies and the trial measured averages rather than what any one person should expect.
The most common side effects are gastrointestinal: nausea, reduced appetite, and sometimes loose stool in the first few weeks as the body adjusts. These tend to settle as the dose stabilizes, and most people find them manageable. Serious adverse effects are uncommon but real, which is part of why physician oversight matters for a medication in this class.
compounded tirzepatide: same molecule, different cost
Compounded tirzepatide is the same active molecule as Mounjaro® and Zepbound®, prescribed by a licensed U.S. physician and filled by a licensed U.S. pharmacy. Compounded and generic are different things. There is no generic tirzepatide in the United States. Compounded means the pharmacy produces the medication from pharmaceutical-grade ingredient for a specific patient, with your name on the label and your physician's approval behind it.
For the distinction between compounded and generic, the compounded vs. generic explainer covers it clearly. For the regulatory background on how compounded GLP-1 prescribing operates in the current environment, the compounded GLP-1 regulatory guide has the full context.
What arrives: a compounded preparation with your name on the label, clear dosing instructions, shipped from a licensed U.S. pharmacy after a licensed U.S. physician approves your prescription.
how the visit works
The process starts with an online intake, about 2 minutes. A licensed U.S. physician reviews your health history and goals. If tirzepatide is appropriate for you, a prescription goes to a licensed U.S. pharmacy, which ships directly to your door. You're charged only after a provider approves.
Most protocols start at a low dose and increase gradually over several weeks. This titration approach both minimizes early GI side effects and mirrors the clinical standard. Your physician monitors progress and adjusts the dose through your patient account.
For current pricing and what arrives in your first shipment, the intake below has the details.
what to expect and when
Appetite changes tend to show up in the first one to two weeks. Weight loss itself takes longer, building over months as the dose reaches its effective level. Most people see meaningful changes in body composition at the 8 to 12 week mark.
It works well alongside adequate protein and sleep, not because the medication requires either, but because both factors affect how your body responds to a caloric deficit: more lean mass preserved, more fat lost.
The timeline lengthens for some people and shortens for others. What doesn't vary much is the direction. If tirzepatide works for you, the trajectory is down and it tends to stay down while you're on it.
Sources & references
- [1]Jastreboff AM, Aronne LJ, Ahmad NN, et al. 'Tirzepatide Once Weekly for the Treatment of Obesity' (SURMOUNT-1). New England Journal of Medicine, 2022; 387(3):205-216. PubMed ↩
- [2]Aronne LJ, Horn DB, le Roux CW, et al. 'Tirzepatide as Compared with Semaglutide for the Treatment of Obesity' (SURMOUNT-5). New England Journal of Medicine, 2025; 393(1):26-36. PubMed ↩
Frequently asked questions
Is compounded tirzepatide the same as Mounjaro or Zepbound?
It contains the same active molecule. Mounjaro and Zepbound are brand-name products made by Eli Lilly. Compounded tirzepatide is produced by a licensed U.S. pharmacy using the same pharmaceutical-grade ingredient, prescribed by a licensed physician, with your name on the label. There is no generic tirzepatide in the United States. Compounded and generic are not the same thing.
Do I need a prescription for tirzepatide?
Yes. Tirzepatide is a prescription medication regardless of whether it's the branded or compounded form. You complete a short online intake, a licensed U.S. physician reviews it, and if tirzepatide is appropriate for you, they write the prescription. You never receive the medication without a physician's approval.
How much does compounded tirzepatide cost?
Current pricing is on the GLP-1 weight loss page. The cost can change and we want you to see the live number rather than a stale one printed here.
What are the most common side effects?
Nausea, reduced appetite, and GI discomfort are most common in the first few weeks as your body adjusts to the medication. These tend to improve as the dose stabilizes. The gradual titration approach most protocols use is designed to minimize them. Serious side effects are uncommon but worth discussing with your provider, which is part of why physician oversight matters.
How long before I see results?
Appetite changes often show up within the first one to two weeks. Meaningful weight loss typically builds over two to three months as the dose reaches its effective level. Most people see their strongest rate of change between months two and six.
This article is for general information and is not medical advice. Pepvio treatments are prescription medications: a licensed US physician reviews every intake and prescribes only when clinically appropriate. Individual results vary.
Ready to get started?
A short intake form, reviewed by a licensed U.S. physician. You're only charged if a prescription is written.
See if GLP-1 is right for meKeep reading
NAD+ Protocols Explained: Why Injectable Beats Oral Every Time
NAD+ is the coenzyme your cells run on, and its age-related decline is one of the clearest biomarkers of aging. Oral NMN and NR supplements have proliferated, but the pharmacokinetics are weak. Here's what the research actually says about injectable NAD+, how it's dosed, and why the biohacker community has moved toward it.
Read articleMetformin for Longevity: Why Peter Attia Reconsidered His Position
Peter Attia publicly backed off metformin as a longevity recommendation around 2022-2023, citing research on mitochondrial adaptations to exercise. Here's the full arc: the original rationale, the specific findings that changed his mind, the TAME trial context, and where other longevity clinicians have landed. An authority-content read for anyone tracking the metformin-longevity debate.
Read articleNAD+ Injections vs Oral NMN: Bioavailability, Cost, and Why Biohackers Picked a Side
NAD+ precursors come in several forms (injectable NAD+, oral NMN, oral NR, and IV) and the bioavailability debate between them is one of the more technical arguments in the longevity space. Here's what the published research on tissue-level NAD+ actually shows, how the cost structures compare, and why most informed biohackers have converged on a specific answer.
Read article